Status:
COMPLETED
Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR)
Lead Sponsor:
Sonex Health, Inc.
Conditions:
Carpal Tunnel Syndrome
CTS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Study to compare the safety and effectiveness of carpal tunnel release with ultrasound guidance (CTR-US) vs. mini-open carpal tunnel release (mOCTR) in patients with symptomatic carpal tunnel syndrome...
Eligibility Criteria
Inclusion
- ≥18 years of age
- Clinical diagnosis of unilateral or bilateral idiopathic CTS
- CTS-6 score \>12 in target hand
- Absence of carpal tunnel symptoms in the contralateral hand that interfere with normal daily activities or work at the time of consent and are not anticipated to interfere with return to activities or return to work within at least 3 months post-operatively
- Median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region of the target hand measured by diagnostic ultrasound
- Prior failure of one or more nonsurgical treatment options for the target hand (e.g., physical activity modification, bracing, splinting, corticosteroid injection)
- Subject agrees to complete follow-up questionnaires over a 12-month period
- Subject has a valid mobile phone number and email address to receive and answer follow-up questionnaires
Exclusion
- Prior surgery on the target wrist or hand with the exception of trigger finger that has clinically recovered
- History of prior surgical CTR procedure in the target hand
- History of prior surgical CTR in the contralateral hand within 3 months of enrollment or with persistent symptoms that interfere with normal daily activities or work at the time of consent
- Corticosteroid injection in the target wrist or hand within 6 weeks of study procedure date
- Presence of additional process in the target wrist or hand requiring additional intervention beyond carpal tunnel release (e.g. neurolysis, mass removal, tenosynovectomy)
- Clinically significant degenerative arthritis of the upper limb (shoulder to hand) on the target side
- Clinically significant inflammatory disease (including tenosynovitis) of the upper limb (shoulder to hand) on the target side
- Clinically significant trauma or deformity of the upper limb (shoulder to hand) on the target side
- Clinically significant vascular disease (including Raynaud's phenomenon) of the upper limb (shoulder to hand) on the target side
- Clinically significant neurological disorder (including complex regional pain syndrome) of the upper limb (shoulder to hand) on the target side
- Planned surgical or interventional procedure on the contralateral wrist or hand
- Systemic inflammatory disease (e.g., rheumatoid arthritis, lupus)
- Amyloidosis
- Chronic renal insufficiency requiring dialysis
- Diabetes not controlled by a stable dose of medication over the past three months
- Uncontrolled thyroid disease
- Pregnant or planning pregnancy in the next 12 months
- Workers compensation subjects
- Inability to provide a legally acceptable Informed Consent Form and/or comply with all follow-up requirements
- Subject has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations
Key Trial Info
Start Date :
August 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT05405218
Start Date
August 8 2022
End Date
March 30 2024
Last Update
June 5 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Sierra Orthopedic Institute
Sonora, California, United States, 95370
2
Orthopedic Associates
Fort Walton Beach, Florida, United States, 32547
3
Tri-State Orthopaedics
Evansville, Indiana, United States, 47715
4
Indiana Hand to Shoulder
Indianapolis, Indiana, United States, 46260